nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—HTR2A—vein—ovarian cancer	0.0709	0.0915	CbGeAlD
Sertindole—HTR1E—myometrium—ovarian cancer	0.0614	0.0791	CbGeAlD
Sertindole—DRD4—testis—ovarian cancer	0.0335	0.0432	CbGeAlD
Sertindole—HTR1E—female gonad—ovarian cancer	0.0326	0.042	CbGeAlD
Sertindole—ADRA1D—epithelium—ovarian cancer	0.0295	0.0381	CbGeAlD
Sertindole—ADRA1D—female reproductive system—ovarian cancer	0.0219	0.0283	CbGeAlD
Sertindole—KCNH2—myometrium—ovarian cancer	0.0209	0.0269	CbGeAlD
Sertindole—ADRA1A—epithelium—ovarian cancer	0.0169	0.0219	CbGeAlD
Sertindole—HTR1B—female reproductive system—ovarian cancer	0.0169	0.0218	CbGeAlD
Sertindole—HRH1—myometrium—ovarian cancer	0.0167	0.0216	CbGeAlD
Sertindole—ADRA2A—myometrium—ovarian cancer	0.0164	0.0212	CbGeAlD
Sertindole—HTR1D—female reproductive system—ovarian cancer	0.0164	0.0211	CbGeAlD
Sertindole—KCNH2—uterine cervix—ovarian cancer	0.0162	0.0209	CbGeAlD
Sertindole—HTR2C—female reproductive system—ovarian cancer	0.0162	0.0209	CbGeAlD
Sertindole—SLC6A4—female reproductive system—ovarian cancer	0.0154	0.0198	CbGeAlD
Sertindole—KCNH2—endometrium—ovarian cancer	0.0147	0.0189	CbGeAlD
Sertindole—KCNH2—uterus—ovarian cancer	0.0135	0.0174	CbGeAlD
Sertindole—HTR2A—embryo—ovarian cancer	0.0134	0.0173	CbGeAlD
Sertindole—HRH1—epithelium—ovarian cancer	0.0131	0.0169	CbGeAlD
Sertindole—HRH1—uterine cervix—ovarian cancer	0.013	0.0168	CbGeAlD
Sertindole—ADRA2A—uterine cervix—ovarian cancer	0.0128	0.0165	CbGeAlD
Sertindole—HRH1—decidua—ovarian cancer	0.0124	0.016	CbGeAlD
Sertindole—ADRA2A—decidua—ovarian cancer	0.0122	0.0157	CbGeAlD
Sertindole—KCNH2—female reproductive system—ovarian cancer	0.0122	0.0157	CbGeAlD
Sertindole—HRH1—endometrium—ovarian cancer	0.0118	0.0152	CbGeAlD
Sertindole—ADRA2A—endometrium—ovarian cancer	0.0116	0.0149	CbGeAlD
Sertindole—KCNH2—bone marrow—ovarian cancer	0.0115	0.0148	CbGeAlD
Sertindole—KCNH2—female gonad—ovarian cancer	0.0111	0.0143	CbGeAlD
Sertindole—KCNH2—vagina—ovarian cancer	0.011	0.0142	CbGeAlD
Sertindole—HTR2A—epithelium—ovarian cancer	0.011	0.0141	CbGeAlD
Sertindole—ADRA2A—gonad—ovarian cancer	0.0107	0.0138	CbGeAlD
Sertindole—ADRA2A—uterus—ovarian cancer	0.0106	0.0137	CbGeAlD
Sertindole—DRD2—testis—ovarian cancer	0.00996	0.0128	CbGeAlD
Sertindole—KCNH2—testis—ovarian cancer	0.00981	0.0127	CbGeAlD
Sertindole—HRH1—female reproductive system—ovarian cancer	0.00975	0.0126	CbGeAlD
Sertindole—ADRA2A—female reproductive system—ovarian cancer	0.00957	0.0123	CbGeAlD
Sertindole—HTR2A—gonad—ovarian cancer	0.00911	0.0118	CbGeAlD
Sertindole—HRH1—female gonad—ovarian cancer	0.00887	0.0114	CbGeAlD
Sertindole—HRH1—vagina—ovarian cancer	0.00881	0.0114	CbGeAlD
Sertindole—ADRA2A—female gonad—ovarian cancer	0.00871	0.0112	CbGeAlD
Sertindole—ADRA2A—vagina—ovarian cancer	0.00866	0.0112	CbGeAlD
Sertindole—Domperidone—ABCB1—ovarian cancer	0.00817	0.385	CrCbGaD
Sertindole—HTR2A—female reproductive system—ovarian cancer	0.00814	0.0105	CbGeAlD
Sertindole—HRH1—testis—ovarian cancer	0.00787	0.0101	CbGeAlD
Sertindole—ADRA2A—testis—ovarian cancer	0.00773	0.00996	CbGeAlD
Sertindole—CYP3A4—female reproductive system—ovarian cancer	0.00754	0.00972	CbGeAlD
Sertindole—CYP2D6—female reproductive system—ovarian cancer	0.00742	0.00956	CbGeAlD
Sertindole—HTR2A—vagina—ovarian cancer	0.00736	0.00949	CbGeAlD
Sertindole—KCNH2—lymph node—ovarian cancer	0.00711	0.00917	CbGeAlD
Sertindole—Pimozide—ABCB1—ovarian cancer	0.00682	0.322	CrCbGaD
Sertindole—CYP2D6—female gonad—ovarian cancer	0.00675	0.0087	CbGeAlD
Sertindole—HTR2A—testis—ovarian cancer	0.00657	0.00847	CbGeAlD
Sertindole—Haloperidol—ABCB1—ovarian cancer	0.00623	0.294	CrCbGaD
Sertindole—CYP2D6—testis—ovarian cancer	0.00598	0.00772	CbGeAlD
Sertindole—HRH1—lymph node—ovarian cancer	0.0057	0.00735	CbGeAlD
Sertindole—ADRA2A—lymph node—ovarian cancer	0.0056	0.00722	CbGeAlD
Sertindole—HRH1—Signaling Pathways—ERBB2—ovarian cancer	3.12e-05	0.000153	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—PIK3CA—ovarian cancer	3.12e-05	0.000153	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—KRAS—ovarian cancer	3.11e-05	0.000153	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—IL6—ovarian cancer	3.11e-05	0.000153	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MMP9—ovarian cancer	3.1e-05	0.000153	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MMP9—ovarian cancer	3.09e-05	0.000152	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PTEN—ovarian cancer	3.09e-05	0.000152	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MTOR—ovarian cancer	3.09e-05	0.000152	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	3.09e-05	0.000152	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MTOR—ovarian cancer	3.08e-05	0.000151	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PIK3CB—ovarian cancer	3.08e-05	0.000151	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PTEN—ovarian cancer	3.07e-05	0.000151	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—ERBB2—ovarian cancer	3.06e-05	0.000151	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—KRAS—ovarian cancer	3.06e-05	0.000151	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CCND1—ovarian cancer	3.05e-05	0.00015	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MAPK3—ovarian cancer	3.03e-05	0.000149	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MAPK3—ovarian cancer	3.03e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	3.02e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	3.02e-05	0.000149	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CTNNB1—ovarian cancer	3.02e-05	0.000148	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CXCL8—ovarian cancer	3.01e-05	0.000148	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—AKT1—ovarian cancer	3.01e-05	0.000148	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—AKT1—ovarian cancer	3e-05	0.000147	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—HRAS—ovarian cancer	2.99e-05	0.000147	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	2.97e-05	0.000146	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CXCL8—ovarian cancer	2.96e-05	0.000146	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MMP9—ovarian cancer	2.96e-05	0.000145	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	2.95e-05	0.000145	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	2.94e-05	0.000145	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MYC—ovarian cancer	2.94e-05	0.000145	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MYC—ovarian cancer	2.94e-05	0.000145	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—PIK3CA—ovarian cancer	2.94e-05	0.000145	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—HRAS—ovarian cancer	2.94e-05	0.000145	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PTEN—ovarian cancer	2.94e-05	0.000145	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—PIK3CA—ovarian cancer	2.92e-05	0.000144	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	2.91e-05	0.000143	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	2.9e-05	0.000143	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PTEN—ovarian cancer	2.9e-05	0.000143	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	2.9e-05	0.000142	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	2.9e-05	0.000142	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CDKN1B—ovarian cancer	2.89e-05	0.000142	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CASP3—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL2—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MAPK1—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MAPK1—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—EGFR—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—EGFR—ovarian cancer	2.88e-05	0.000142	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—AKT1—ovarian cancer	2.87e-05	0.000141	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—IL6—ovarian cancer	2.87e-05	0.000141	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	2.86e-05	0.000141	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—AKT1—ovarian cancer	2.86e-05	0.000141	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—PIK3CA—ovarian cancer	2.86e-05	0.000141	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.85e-05	0.00014	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TP53—ovarian cancer	2.85e-05	0.00014	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	2.84e-05	0.00014	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CASP3—ovarian cancer	2.84e-05	0.00014	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	2.84e-05	0.000139	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL2—ovarian cancer	2.83e-05	0.000139	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CASP3—ovarian cancer	2.83e-05	0.000139	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL2—ovarian cancer	2.83e-05	0.000139	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TP53—ovarian cancer	2.82e-05	0.000139	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—IL6—ovarian cancer	2.82e-05	0.000139	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—IL6—ovarian cancer	2.81e-05	0.000138	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—PIK3CA—ovarian cancer	2.81e-05	0.000138	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CCND1—ovarian cancer	2.81e-05	0.000138	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	2.81e-05	0.000138	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	2.81e-05	0.000138	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	2.8e-05	0.000138	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.79e-05	0.000137	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—VEGFA—ovarian cancer	2.79e-05	0.000137	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	2.78e-05	0.000137	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	2.78e-05	0.000137	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL2—ovarian cancer	2.77e-05	0.000136	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	2.77e-05	0.000136	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TP53—ovarian cancer	2.77e-05	0.000136	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CCND1—ovarian cancer	2.76e-05	0.000136	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	2.76e-05	0.000136	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—STAT3—ovarian cancer	2.76e-05	0.000136	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CCND1—ovarian cancer	2.76e-05	0.000136	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—NRAS—ovarian cancer	2.75e-05	0.000135	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—STAT3—ovarian cancer	2.75e-05	0.000135	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—NRAS—ovarian cancer	2.74e-05	0.000135	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	2.74e-05	0.000135	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CTNNB1—ovarian cancer	2.73e-05	0.000134	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MMP9—ovarian cancer	2.73e-05	0.000134	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—HRAS—ovarian cancer	2.72e-05	0.000134	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TP53—ovarian cancer	2.72e-05	0.000134	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—KRAS—ovarian cancer	2.72e-05	0.000134	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—KRAS—ovarian cancer	2.72e-05	0.000134	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PTEN—ovarian cancer	2.71e-05	0.000133	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	2.7e-05	0.000133	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—HRAS—ovarian cancer	2.7e-05	0.000133	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	2.7e-05	0.000133	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MMP9—ovarian cancer	2.68e-05	0.000132	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	2.68e-05	0.000132	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	2.68e-05	0.000132	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MMP9—ovarian cancer	2.68e-05	0.000132	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PTEN—ovarian cancer	2.67e-05	0.000131	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PTEN—ovarian cancer	2.66e-05	0.000131	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	2.65e-05	0.000131	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—HRAS—ovarian cancer	2.64e-05	0.00013	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—AKT1—ovarian cancer	2.64e-05	0.00013	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	2.64e-05	0.00013	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	2.63e-05	0.00013	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	2.63e-05	0.000129	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	2.63e-05	0.000129	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	2.62e-05	0.000129	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	2.62e-05	0.000129	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	2.61e-05	0.000128	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	2.61e-05	0.000128	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—IL6—ovarian cancer	2.6e-05	0.000128	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—HRAS—ovarian cancer	2.6e-05	0.000128	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	2.6e-05	0.000128	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—AKT1—ovarian cancer	2.6e-05	0.000128	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.59e-05	0.000127	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—IL6—ovarian cancer	2.58e-05	0.000127	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	2.58e-05	0.000127	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL2—ovarian cancer	2.58e-05	0.000127	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	2.57e-05	0.000126	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MYC—ovarian cancer	2.56e-05	0.000126	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MYC—ovarian cancer	2.55e-05	0.000125	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	2.55e-05	0.000125	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—TYMS—ovarian cancer	2.54e-05	0.000125	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—IL6—ovarian cancer	2.53e-05	0.000124	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	2.51e-05	0.000124	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	2.51e-05	0.000124	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.51e-05	0.000123	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	2.51e-05	0.000123	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—EGFR—ovarian cancer	2.51e-05	0.000123	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	2.5e-05	0.000123	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	2.5e-05	0.000123	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	2.5e-05	0.000123	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—EGFR—ovarian cancer	2.5e-05	0.000123	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—IL6—ovarian cancer	2.49e-05	0.000122	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	2.49e-05	0.000122	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—VEGFA—ovarian cancer	2.45e-05	0.00012	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MYC—ovarian cancer	2.44e-05	0.00012	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	2.44e-05	0.00012	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	2.43e-05	0.000119	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—STAT3—ovarian cancer	2.42e-05	0.000119	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—NRAS—ovarian cancer	2.42e-05	0.000119	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TP53—ovarian cancer	2.42e-05	0.000119	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TP53—ovarian cancer	2.42e-05	0.000119	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	2.41e-05	0.000118	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—VEGFA—ovarian cancer	2.4e-05	0.000118	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—AKT1—ovarian cancer	2.4e-05	0.000118	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	2.39e-05	0.000118	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	2.39e-05	0.000117	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—AKT1—ovarian cancer	2.38e-05	0.000117	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—STAT3—ovarian cancer	2.38e-05	0.000117	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—STAT3—ovarian cancer	2.38e-05	0.000117	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—NRAS—ovarian cancer	2.38e-05	0.000117	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—NRAS—ovarian cancer	2.37e-05	0.000117	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—KRAS—ovarian cancer	2.37e-05	0.000117	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	2.37e-05	0.000116	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	2.36e-05	0.000116	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—KRAS—ovarian cancer	2.36e-05	0.000116	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	2.33e-05	0.000115	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—AKT1—ovarian cancer	2.33e-05	0.000115	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	2.33e-05	0.000115	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK3—ovarian cancer	2.32e-05	0.000114	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	2.31e-05	0.000114	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—HRAS—ovarian cancer	2.31e-05	0.000114	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—AKT1—ovarian cancer	2.3e-05	0.000113	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	2.28e-05	0.000112	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK3—ovarian cancer	2.27e-05	0.000112	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	2.26e-05	0.000111	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MYC—ovarian cancer	2.25e-05	0.000111	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	2.23e-05	0.00011	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MYC—ovarian cancer	2.22e-05	0.000109	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL6—ovarian cancer	2.21e-05	0.000109	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL6—ovarian cancer	2.21e-05	0.000109	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MYC—ovarian cancer	2.21e-05	0.000109	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK1—ovarian cancer	2.2e-05	0.000108	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—EGFR—ovarian cancer	2.2e-05	0.000108	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	2.19e-05	0.000108	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.19e-05	0.000108	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	2.18e-05	0.000107	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MYC—ovarian cancer	2.17e-05	0.000107	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	2.17e-05	0.000107	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	2.17e-05	0.000107	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—EGFR—ovarian cancer	2.17e-05	0.000107	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	2.17e-05	0.000107	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	2.16e-05	0.000106	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK1—ovarian cancer	2.16e-05	0.000106	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—EGFR—ovarian cancer	2.16e-05	0.000106	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	2.12e-05	0.000104	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	2.12e-05	0.000104	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TP53—ovarian cancer	2.11e-05	0.000104	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TP53—ovarian cancer	2.1e-05	0.000103	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—KRAS—ovarian cancer	2.08e-05	0.000102	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	2.07e-05	0.000102	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	2.07e-05	0.000102	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CAV1—ovarian cancer	2.05e-05	0.000101	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—KRAS—ovarian cancer	2.05e-05	0.000101	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PIK3CA—ovarian cancer	2.05e-05	0.000101	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—KRAS—ovarian cancer	2.04e-05	0.0001	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	2.04e-05	0.0001	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—AKT1—ovarian cancer	2.04e-05	0.0001	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MYC—ovarian cancer	2.02e-05	9.91e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HRAS—ovarian cancer	2.01e-05	9.91e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TP53—ovarian cancer	2.01e-05	9.87e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	2e-05	9.86e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HRAS—ovarian cancer	2e-05	9.86e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	1.97e-05	9.7e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	1.97e-05	9.7e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL6—ovarian cancer	1.93e-05	9.48e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	1.92e-05	9.43e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL6—ovarian cancer	1.92e-05	9.43e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	1.91e-05	9.4e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PTEN—ovarian cancer	1.89e-05	9.3e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	1.88e-05	9.25e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	1.88e-05	9.23e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.87e-05	9.18e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	1.86e-05	9.16e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TP53—ovarian cancer	1.85e-05	9.1e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	1.84e-05	9.06e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL6—ovarian cancer	1.84e-05	9.03e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TP53—ovarian cancer	1.82e-05	8.95e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TP53—ovarian cancer	1.82e-05	8.93e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TP53—ovarian cancer	1.78e-05	8.76e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—AKT1—ovarian cancer	1.78e-05	8.75e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—AKT1—ovarian cancer	1.77e-05	8.7e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HRAS—ovarian cancer	1.77e-05	8.7e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HRAS—ovarian cancer	1.74e-05	8.56e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HRAS—ovarian cancer	1.74e-05	8.54e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	1.71e-05	8.42e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	1.7e-05	8.38e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	1.69e-05	8.33e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL6—ovarian cancer	1.69e-05	8.33e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—AKT1—ovarian cancer	1.67e-05	8.22e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL6—ovarian cancer	1.67e-05	8.19e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL6—ovarian cancer	1.66e-05	8.17e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TP53—ovarian cancer	1.66e-05	8.14e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.64e-05	8.07e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL6—ovarian cancer	1.63e-05	8.02e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	1.58e-05	7.79e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—AKT1—ovarian cancer	1.56e-05	7.68e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—AKT1—ovarian cancer	1.54e-05	7.56e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—AKT1—ovarian cancer	1.53e-05	7.54e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL6—ovarian cancer	1.52e-05	7.45e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	1.5e-05	7.4e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.43e-05	7.03e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	1.4e-05	6.88e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.33e-05	6.56e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PTEN—ovarian cancer	1.24e-05	6.08e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—AKT1—ovarian cancer	1.09e-05	5.36e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.72e-06	4.29e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—AKT1—ovarian cancer	7.12e-06	3.5e-05	CbGpPWpGaD
